GERN vs GILD: Which Stock is Better?
Side-by-side comparison of Geron Corp and Gilead Sciences Inc in 2026
GERN
Geron Corp
$1.66
GILD
Gilead Sciences Inc
$139.71
Key Metrics Comparison
| Metric | GERN | GILD | Winner |
|---|---|---|---|
| Market Cap | $1.06B | $174.14B | GILD |
| P/E Ratio | N/A | 20.69 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 97.4% | 78.8% | GERN |
Analyze GERN
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GERN or GILD a better investment?
Comparing GERN and GILD: Geron Corp has a market cap of $1.06B while Gilead Sciences Inc has $174.14B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GERN and GILD?
GERN (Geron Corp) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GERN or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GERN or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for GERN.
Which company is more profitable: GERN or GILD?
Geron Corp (GERN) has higher gross margins at 97.4% compared to 78.8% for GILD.
Which is the larger company: GERN or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.14B compared to $1.06B for GERN.
Should I buy GERN or GILD in 2026?
Both GERN and GILD have investment merit. GERN trades at $1.66 while GILD trades at $139.71. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GERN and GILD stock?
Key differences: Market Cap ($1.06B vs $174.14B), P/E Ratio (N/A vs 20.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (97.4% vs 78.8%).